{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:29:17Z","timestamp":1793035757727,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100024597","name":"Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation, Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajicjournal.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajic.2024.10.013","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T22:16:54Z","timestamp":1729289814000},"page":"314-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The patterns of antifungal use and risk factors associated with mortality in patients with invasive candidiasis and aspergillosis infections among patients who were received infectious disease specialist consultation prior to and during the COVID-19 pandemic in a resource-limited setting: A retrospective cohort study"],"prefix":"10.1016","volume":"53","author":[{"given":"Supavit","family":"Vaivoothpinyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9428-6131","authenticated-orcid":false,"given":"Kittiya","family":"Jantarathaneewat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard C.","family":"Camins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyaporn","family":"Apisarnthanarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-2957","authenticated-orcid":false,"given":"Sasinuch","family":"Rutjanawech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6758-2022","authenticated-orcid":false,"given":"Anucha","family":"Apisarnthanarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2024.10.013_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2024.10.013_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: a systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2024.10.013_bib3","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/cid\/ciaa1594","article-title":"Candidemia in coronavirus disease 2019 (COVID-19) patients: incidence and characteristics in a prospective cohort compared with historical non-COVID-19 controls","volume":"73","author":"Mastrangelo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.10.013_bib4","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajic.2024.10.013_bib5","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.10.013_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive Candida infection in critically Ill patients: a systematic review and meta-analysis","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2024.10.013_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.36519\/idcm.2022.144","article-title":"The effect of the pandemic on antifungal use: what has changed?","volume":"3","author":"Avkan-O\u011fuz","year":"2022","journal-title":"Infect Dis Clin Microbiol"},{"key":"10.1016\/j.ajic.2024.10.013_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s13054-020-03307-5","article-title":"No time for pending confirmation of invasive fungal disease in critically ill COVID-19 patients-think empirical treatment","volume":"24","author":"Bienvenu","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ajic.2024.10.013_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2024.10.013_bib10","unstructured":"Clinical and Laboratory Standards Institute. When should antifungal susceptibility testing be performed for Candida species isolated from clinical specimens? Published February 2019. Accessed July 8, 2024. https:\/\/clsi.org\/about\/blog\/ast-news-update-2019-practical-tips-1\/."},{"key":"10.1016\/j.ajic.2024.10.013_bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2024.10.013_bib12","unstructured":"National Cancer Institute Division of Cancer Treatment and Diagnosis. Common terminology criteria for adverse events (CTCAE). Published November 2017. Accessed July 8, 2024. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40."},{"key":"10.1016\/j.ajic.2024.10.013_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13054-022-04270-z","article-title":"Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis","volume":"26","author":"Bienvenu","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.ajic.2024.10.013_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/IDR.S242187","article-title":"Epidemiology and mortality-associated factors of invasive fungal disease in elderly patients: a 20-year retrospective study from Southern China","volume":"13","author":"Gong","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ajic.2024.10.013_bib15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ajic.2024.10.013_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186422","article-title":"Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: an 11-year follow-up report from Taiwan","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2024.10.013_bib17","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.354","article-title":"Increase in the incidence of Candida parapsilosis and Candida tropicalis bloodstream infections during the coronavirus disease 2019 (COVID-19) pandemic","volume":"3","author":"Pienthong","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.ajic.2024.10.013_bib18","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2022.35","article-title":"Strategies to limit invasive fungal infection in a coronavirus disease 2019 (COVID-19) intensive care unit: the role of infection prevention for renovation and construction in resource-limited settings","volume":"2","author":"Sathitakorn","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.ajic.2024.10.013_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/civ297","article-title":"Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation","volume":"61","author":"Kanamori","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324007983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655324007983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T21:16:28Z","timestamp":1741036588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655324007983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0196655324007983"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2024.10.013","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The patterns of antifungal use and risk factors associated with mortality in patients with invasive candidiasis and aspergillosis infections among patients who were received infectious disease specialist consultation prior to and during the COVID-19 pandemic in a resource-limited setting: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2024.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}